Impact of Teacher Training and the Introduction of Early Adjustments on the Developmental Trajectory of Children at Risk of SLLD in Pre-school.
NCT ID: NCT06062147
Last Updated: 2025-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
165 participants
INTERVENTIONAL
2023-09-22
2024-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
NCT04926311
Language and Motor Skills of Preterm Infants in Pre-school Age: Diagnosis and Early Intervention
NCT01426659
Efficacy of a Pragmatic Intervention to Improve Adaptation to Context and Interlocutor
NCT05127863
Maximizing Outcomes for Preschoolers With Developmental Language Disorders
NCT03782493
Language and Motricity in Preterm School Age Children
NCT02811029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
teacher training
Teacher training and support for teachers in setting up specific arrangements.
Teacher training
Training for teachers in the intervention arm in the learning process, SLLD and early warning signs, with an identification grid. Observation of identified pupils and implementation of educational and environmental adjustments.
control class
Teacher will proceed in the usual way, referring to the procedures put in place by the national education system for identifying and referring children at risk
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teacher training
Training for teachers in the intervention arm in the learning process, SLLD and early warning signs, with an identification grid. Observation of identified pupils and implementation of educational and environmental adjustments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In a kindergarten school with at least 3 classes of primary school age children.
* At least 5 years old on 31/12/2023.
* Whose 2 parents have given their consent (the consent of a single parent if no contact is possible with the second parent despite repeated attempts)
* Have received age-appropriate explanations about the study and have not refused to take part.
Exclusion Criteria
* In a kindergarten school with fewer than 3 classes, making it impossible to randomise the school
* Under 5 years of age on 31 December of the current school year.
* Under guardianship
5 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Magali CARBONNNIER, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Père FAVRON
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de La Réunion
Saint-Denis, , Reunion
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01501-44
Identifier Type: OTHER
Identifier Source: secondary_id
2023/CHU/28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.